07:19:14 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



THC Biomed Intl Ltd
Symbol THC
Shares Issued 163,676,056
Close 2023-07-04 C$ 0.045
Market Cap C$ 7,365,423
Recent Sedar Documents

THC Biomed releases summer product line

2023-07-04 07:35 ET - News Release

Mr. John Miller reports

THC BIOMED INTL LTD. LAUNCHES NEW SUMMER CANNABIS PRODUCT: THC KISS STRAWBERRY TANGERINE GUMMIES

THC Biomed Intl Ltd. has released its summer product line, featuring the THC Kiss strawberry tangerine gummies with 10 per cent tetrahydrocannabinol.

The launch of these full-spectrum cannabis gummies represents the company's commitment to product innovation and diversification. The company continues to work diligently to improve shareholder value and attract investor interest in the rapidly evolving cannabis market.

"Our new THC Kiss strawberry tangerine gummies are the perfect addition to our product line for the summer season," said John Miller, chief executive officer of THC Biomed. "Crafted with the finest ingredients, these gummies reflect our dedication to quality, consistency and customer satisfaction. We are optimistic that this launch will continue to position THC Biomed as a frontrunner in the cannabis product market."

The THC Kiss strawberry tangerine gummies are full-spectrum cannabis products, made with the purest ingredients, promising consumers a superior experience. This product launch underlines THC Biomed's ongoing efforts to expand its product portfolio and meet consumer demand for innovative, high-quality cannabis products.

About THC Biomed Intl Ltd.

As a leader in the Canadian cannabis industry, THC Biomed is licensed to cultivate and sell an extensive range of cannabis products. Its dedication to product development, scientific research and fostering a diverse cannabis industry distinguishes the company as a top player within the sector.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.